HC Wainwright & Co. Maintains Buy on 89bio, Maintains $31 Price Target
Portfolio Pulse from Benzinga Newsdesk
HC Wainwright & Co. analyst Ed Arce maintains a Buy rating on 89bio (NASDAQ:ETNB) and keeps the price target at $31.

March 27, 2024 | 5:53 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
HC Wainwright & Co. reaffirms a Buy rating on 89bio, with a steady price target of $31.
The reaffirmation of a Buy rating and a significant price target of $31 by a reputable analyst firm like HC Wainwright & Co. typically signals a strong vote of confidence in the company's future performance. This endorsement is likely to positively influence investor sentiment and potentially drive up the stock price in the short term.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100